1
|
Bakker OJ, van Santvoort HC, van Brunschot S, Ali UA, Besselink MG, Boermeester MA, Bollen TL, Bosscha K, Brink MA, Dejong CH, van Geenen EJ, van Goor H, Heisterkamp J, Houdijk AP, Jansen JM, Karsten TM, Manusama ER, Nieuwenhuijs VB, van Ramshorst B, Schaapherder AF, van der Schelling GP, Spanier MBM, Tan A, Vecht J, Weusten BL, Witteman BJ, Akkermans LM, Gooszen HG. Pancreatitis, very early compared with normal start of enteral feeding (PYTHON trial): design and rationale of a randomised controlled multicenter trial. Trials 2011; 12:73. [PMID: 21392395 PMCID: PMC3068962 DOI: 10.1186/1745-6215-12-73] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/16/2010] [Accepted: 03/10/2011] [Indexed: 02/07/2023] Open
Abstract
BACKGROUND In predicted severe acute pancreatitis, infections have a negative effect on clinical outcome. A start of enteral nutrition (EN) within 24 hours of onset may reduce the number of infections as compared to the current practice of starting an oral diet and EN if necessary at 3-4 days after admission. METHODS/DESIGN The PYTHON trial is a randomised controlled, parallel-group, superiority multicenter trial. Patients with predicted severe acute pancreatitis (Imrie-score ≥ 3 or APACHE-II score ≥ 8 or CRP > 150 mg/L) will be randomised to EN within 24 hours or an oral diet and EN if necessary, after 72 hours after hospital admission.During a 3-year period, 208 patients will be enrolled from 20 hospitals of the Dutch Pancreatitis Study Group. The primary endpoint is a composite of mortality or infections (bacteraemia, infected pancreatic or peripancreatic necrosis, pneumonia) during hospital stay or within 6 months following randomisation. Secondary endpoints include other major morbidity (e.g. new onset organ failure, need for intervention), intolerance of enteral feeding and total costs from a societal perspective. DISCUSSION The PYTHON trial is designed to show that a very early (< 24 h) start of EN reduces the combined endpoint of mortality or infections as compared to the current practice of an oral diet and EN if necessary at around 72 hours after admission for predicted severe acute pancreatitis. TRIAL REGISTRATION ISRCTN: ISRCTN18170985.
Collapse
Affiliation(s)
- Olaf J Bakker
- Dept. of Surgery, University Medical Center Utrecht, HP G04.228, PO 85500, 3508 GA Utrecht; The Netherlands
| | - Hjalmar C van Santvoort
- Dept. of Surgery, University Medical Center Utrecht, HP G04.228, PO 85500, 3508 GA Utrecht; The Netherlands
| | - Sandra van Brunschot
- Dept. of Surgery, Radboud University Nijmegen Medical Centre, HP 630, PO 9101, 6500 HB Nijmegen; The Netherlands
| | - Usama Ahmed Ali
- Dept. of Surgery, University Medical Center Utrecht, HP G04.228, PO 85500, 3508 GA Utrecht; The Netherlands
| | - Marc G Besselink
- Dept. of Surgery, University Medical Center Utrecht, HP G04.228, PO 85500, 3508 GA Utrecht; The Netherlands
| | - Marja A Boermeester
- Dept. of Surgery, Academic Medical Center Amsterdam, PO 22660, 1100 DD Amsterdam; The Netherlands
| | - Thomas L Bollen
- Dept. of Radiology, St Antonius Hospital Nieuwegein, PO 2500, 3430 EM Nieuwegein; The Netherlands
| | - Koop Bosscha
- Dept. of Surgery, Jeroen Bosch Hospital, PO 90153, 5200 ME Den Bosch; The Netherlands
| | - Menno A Brink
- Dept. of Gastroenterology, Meander Medical Center Amersfoort, PO 1502, 3800 BM, Amersfoort; The Netherlands
| | - Cornelis H Dejong
- Dept. of Surgery, Maastricht University Medical Center, PO 5800, 6202 AZ Maastricht; The Netherlands
| | - Erwin J van Geenen
- Dept. of Gastroenterology, VU Medical Center, PO 7057, 1007 MB Amsterdam; The Netherlands
| | - Harry van Goor
- Dept. of Surgery, Radboud University Nijmegen Medical Centre, HP 630, PO 9101, 6500 HB Nijmegen; The Netherlands
| | - Joos Heisterkamp
- Dept. of Surgery, St.Elisabeth Hospital, PO 90151, 5000 LC Tilburg; The Netherlands
| | - Alexander P Houdijk
- Dept. of Surgery, Medical Center Alkmaar, PO 501, 1800 AM Alkmaar; The Netherlands
| | - Jeroen M Jansen
- Dept. of Gastroenterology, Onze Lieve Vrouwe Gasthuis, PO 95500, 1090 HM Amsterdam; The Netherlands
| | - Thom M Karsten
- Dept. of Surgery, Reinier de Graaf Gasthuis, PO 5011, 2600 GA Delft; The Netherlands
| | - Eric R Manusama
- Dept. of Surgery, Medical Center Leeuwarden, PO 888, 8901 BR Leeuwarden; The Netherlands
| | - Vincent B Nieuwenhuijs
- Dept. of Surgery, University Medical Center Groningen, PO 30001, 9700 RB Groningen; The Netherlands
| | - Bert van Ramshorst
- Dept. of Surgery, St Antonius Hospital Nieuwegein, PO 2500, 3430 EM Nieuwegein; The Netherlands
| | | | | | - Marcel BM Spanier
- Dept. of Gastroenterology, Rijnstate Hospital, PO 9555, 6800 TA Arnhem; The Netherlands
| | - Adriaan Tan
- Dept. of Gastroenterology, Canisius Wilhelmina Hospital, PO 9015, 6500 GS Nijmegen; The Netherlands
| | - Juda Vecht
- Dept. of Gastroenterology, Isala Clinics, PO 10400, 8000 GK, Zwolle; The Netherlands
| | - Bas L Weusten
- Dept. of Gastroenterology, St Antonius Hospital Nieuwegein, PO 2500, 3430 EM Nieuwegein; The Netherlands
| | - Ben J Witteman
- Dept. of Gastroenterology, Hospital Gelderse Vallei Ede, PO 9025, 6710 HN Ede; The Netherlands
| | - Louis M Akkermans
- Dept. of Surgery, University Medical Center Utrecht, HP G04.228, PO 85500, 3508 GA Utrecht; The Netherlands
| | - Hein G Gooszen
- Dept. of OR/Evidence Based Surgery, Radboud University Nijmegen Medical Centre, PO 9101, 6500 HB Nijmegen; The Netherlands
| |
Collapse
|